Literature DB >> 19427865

Mitochondria-targeted (2-hydroxyamino-vinyl)-triphenyl-phosphonium releases NO(.) and protects mouse embryonic cells against irradiation-induced apoptosis.

Natalia A Belikova1, Jianfei Jiang, Detcho A Stoyanovsky, Ashley Glumac, Hülya Bayir, Joel S Greenberger, Valerian E Kagan.   

Abstract

Generation of reactive oxygen species by damaged respiratory chain followed by the formation of cytochrome c (cyt c)-cardiolipin (CL) complex with peroxidase activity are early events in apoptosis. By quenching the peroxidase activity of cyt c-CL complexes in mitochondria, nitric oxide can exert anti-apoptotic effects. Therefore, mitochondria-targeted pro-drugs capable of gradual nitric oxide radical (NO*) release are promising radioprotectants. Here we demonstrate that (2-hydroxyamino-vinyl)-triphenyl-phosphonium effectively accumulates in mitochondria, releases NO* upon mitochondrial peroxidase reaction, protects mouse embryonic cells from irradiation-induced apoptosis and increases their clonogenic survival after irradiation. We conclude that mitochondria-targeted peroxidase-activatable NO-donors represent a new interesting class of radioprotectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427865      PMCID: PMC2696693          DOI: 10.1016/j.febslet.2009.04.050

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

Review 1.  Nitric oxide and apoptosis.

Authors:  J Haendeler; A M Zeiher; S Dimmeler
Journal:  Vitam Horm       Date:  1999       Impact factor: 3.421

2.  Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates.

Authors:  Peter Wipf; Jingbo Xiao; Jianfei Jiang; Natalia A Belikova; Vladimir A Tyurin; Mitchell P Fink; Valerian E Kagan
Journal:  J Am Chem Soc       Date:  2005-09-14       Impact factor: 15.419

3.  Nitric oxide inhibits peroxidase activity of cytochrome c.cardiolipin complex and blocks cardiolipin oxidation.

Authors:  Irina I Vlasova; Vladimir A Tyurin; Alexandr A Kapralov; Igor V Kurnikov; Anatoly N Osipov; Maxim V Potapovich; Detcho A Stoyanovsky; Valerian E Kagan
Journal:  J Biol Chem       Date:  2006-03-16       Impact factor: 5.157

Review 4.  Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria.

Authors:  Richard W Horobin; Stefan Trapp; Volkmar Weissig
Journal:  J Control Release       Date:  2007-06-14       Impact factor: 9.776

5.  Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides.

Authors:  Jianfei Jiang; Igor Kurnikov; Natalia A Belikova; Jingbo Xiao; Qing Zhao; Andrew A Amoscato; Rebecca Braslau; Armido Studer; Mitchell P Fink; Joel S Greenberger; Peter Wipf; Valerian E Kagan
Journal:  J Pharmacol Exp Ther       Date:  2006-12-19       Impact factor: 4.030

Review 6.  Selective targeting of bioactive compounds to mitochondria.

Authors:  M P Murphy
Journal:  Trends Biotechnol       Date:  1997-08       Impact factor: 19.536

7.  "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms.

Authors:  L K Keefer; R W Nims; K M Davies; D A Wink
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

8.  Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors.

Authors:  Valerian E Kagan; Vladimir A Tyurin; Jianfei Jiang; Yulia Y Tyurina; Vladimir B Ritov; Andrew A Amoscato; Anatoly N Osipov; Natalia A Belikova; Alexandr A Kapralov; Vidisha Kini; Irina I Vlasova; Qing Zhao; Meimei Zou; Peter Di; Dimitry A Svistunenko; Igor V Kurnikov; Gregory G Borisenko
Journal:  Nat Chem Biol       Date:  2005-08-14       Impact factor: 15.040

Review 9.  Radiation-induced apoptosis: relevance to radiotherapy.

Authors:  W C Dewey; C C Ling; R E Meyn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-11-01       Impact factor: 7.038

Review 10.  Targeting mitochondria.

Authors:  Adam T Hoye; Jennifer E Davoren; Peter Wipf; Mitchell P Fink; Valerian E Kagan
Journal:  Acc Chem Res       Date:  2008-01       Impact factor: 22.384

View more
  13 in total

1.  Multiple triphenylphosphonium cations as a platform for the delivery of a pro-apoptotic peptide.

Authors:  Netanel Kolevzon; Uriel Kuflik; Miriam Shmuel; Sandrine Benhamron; Israel Ringel; Eylon Yavin
Journal:  Pharm Res       Date:  2011-06-02       Impact factor: 4.200

Review 2.  Mitochondria as a target in treatment.

Authors:  Marie-Céline Frantz; Peter Wipf
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

Review 3.  Cardiolipin signaling mechanisms: collapse of asymmetry and oxidation.

Authors:  Valerian E Kagan; Yulia Y Tyurina; Vladimir A Tyurin; Dariush Mohammadyani; Jose Pedro Friedmann Angeli; Sergei V Baranov; Judith Klein-Seetharaman; Robert M Friedlander; Rama K Mallampalli; Marcus Conrad; Hülya Bayir
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

4.  AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro.

Authors:  Bartosz Szczesny; Katalin Módis; Kazunori Yanagi; Ciro Coletta; Sophie Le Trionnaire; Alexis Perry; Mark E Wood; Matthew Whiteman; Csaba Szabo
Journal:  Nitric Oxide       Date:  2014-04-19       Impact factor: 4.427

5.  Improved Total-Body Irradiation Survival by Delivery of Two Radiation Mitigators that Target Distinct Cell Death Pathways.

Authors:  Justin Steinman; Michael Epperly; Wen Hou; John Willis; Hong Wang; Renee Fisher; Bing Liu; Ivet Bahar; Travis McCaw; Valerian Kagan; Hulya Bayir; Jian Yu; Peter Wipf; Song Li; M Saiful Huq; Joel S Greenberger
Journal:  Radiat Res       Date:  2017-11-15       Impact factor: 2.841

Review 6.  Targeted nanoparticles in mitochondrial medicine.

Authors:  Rakesh K Pathak; Nagesh Kolishetti; Shanta Dhar
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-10-27

Review 7.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 8.  Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress.

Authors:  Anna A Shvedova; Antonio Pietroiusti; Bengt Fadeel; Valerian E Kagan
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-06       Impact factor: 4.219

Review 9.  Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions.

Authors:  Valerian E Kagan; Peter Wipf; Detcho Stoyanovsky; Joel S Greenberger; Grigory Borisenko; Natalia A Belikova; Naveena Yanamala; Alejandro K Samhan Arias; Muhammad A Tungekar; Jianfei Jiang; Yulia Y Tyurina; Jing Ji; Judith Klein-Seetharaman; Bruce R Pitt; Anna A Shvedova; Hülya Bayir
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

10.  Strategies for discovery of small molecule radiation protectors and radiation mitigators.

Authors:  Joel S Greenberger; David Clump; Valerian Kagan; Hülya Bayir; John S Lazo; Peter Wipf; Song Li; Xiang Gao; Michael W Epperly
Journal:  Front Oncol       Date:  2012-01-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.